Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

April 16, 2021

Germline mutations and age at onset of lung adenocarcinoma.

Karen L ReckampJeffrey N Weitzel
April 16, 2021

The Prediction of Recurrence in Low-Risk Endometrial Cancer: Is It Time for a Paradigm Shift in Adjuvant Therapy?

Reproductive Sciences
Mohamed LabanAlaa Sayed Hassanin
April 16, 2021

Ranitidine Use and Gastric Cancer Among Persons with Helicobacter pylori.

Digestive Diseases and Sciences
Shria KumarDavid E Kaplan
April 16, 2021
Open Access

A national examination of neighborhood socio-economic disparities in built environment correlates of youth physical activity.

Preventive Medicine Reports
Marissa M Shams-WhiteApril Y Oh
April 16, 2021
Open Access

Socioeconomic factors are associated with the prognosis of Thyroid Cancer.

Journal of Cancer
Yu LiPin Dong
April 16, 2021

Grandmaternal Perinatal Serum DDT in Relation to Granddaughter Early Menarche and Adult Obesity: Three Generations in the Child Health and Development Studies Cohort.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Piera M CirilloBarbara A Cohn
April 14, 2021
Open Access

Germline Mutation Analysis in Sporadic Breast Cancer Cases with Clinical Correlations

MedRxiv : the Preprint Server for Health Sciences
Sadia AjazM. Ali Memon
April 14, 2021
Open Access

Social and Clinical Determinants of COVID-19 Outcomes: Modeling Real-World Data from a Pandemic Epicenter.

MedRxiv : the Preprint Server for Health Sciences
Jyothi ManoharMelissa Boneta Davis
April 14, 2021

Genomic Differences by Race Emerge in Colorectal Cancer.

Cancer Discovery
April 14, 2021
Open Access

Effects of message framing on cervical cancer screening knowledge and intentions related to primary HPV testing.

Cancer Prevention Research
Shannon N OgdenKatharine A Rendle
April 14, 2021

Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.

British Journal of Cancer
Hilary A RobbinsMattias Johansson

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

© 2021 Meta ULC. All rights reserved